期刊文献+

miRNA-199a-3p调控MAP3K4在胃癌中的表达 被引量:8

Overexpression of miRNA-199a-3p targets at expression of MAP3K4 in gastric cancer
下载PDF
导出
摘要 目的探讨胃癌中MIRNA-199A-3P调控候选基因MAP3K4的表达。方法收集35例胃癌及癌旁组织标本,采用茎环逆转录-聚合酶链式反应法检测胃癌组织及癌旁组织中MIR-199A-3P的表达水平,WESTERN BLOT法检测MAP3K4表达;细胞转染法检测MIR-199A-3P调控MAP3K4表达,双荧光素酶报告基因检测系统验证MIR-199A-3P结合MAP3K4的3’UTR的靶位点。结果与癌旁组织相比,胃癌组织MIR-199A-3P高表达,且其候选基因MAP3K4低表达;MIR-199A-3P MIMICS转染抑制MAP3K4表达;MAP3K4是MIR-199A-3P作用的靶基因。结论 MIR-199A-3P是胃癌的一个癌基因,MAP3K4是受其调控的靶基因。 Objective To investigate the effect of miRNA-199a-3p overexpression on the expression of MAP3K4 protein in gastric cancer. Methods 35 gastric cancers and the matched adjacent tissue specimens were collected. Expression of miRNA-199a-3p and MAP3K4 were detected by stem-loop real-time reverse transcription polymerase chain reaction and western blot. Cell transfection was employed to explore the regulation of miRNA-199a -3p on MAP3K4 gene. Luciferase reporter assay was performed to identify target MAP3K4 gene. Results Compared with the adjacent tissue specimens, miRNA-199a-3p was upregulated in the gastric cancers, and MAP3K4 protein was down-regulated in the gastric cancers. Cells transfected with miR- 199a-3p mimics showed lower MAP3K4 protein. MAP3K4 was identified as target gene of miR-199a-3p. Conclusions miRNA-199a-3p acts as an oncogene in gastric cancer and functions by targeting MAP3K4.
出处 《实用医学杂志》 CAS 北大核心 2017年第17期2817-2820,共4页 The Journal of Practical Medicine
基金 武汉市卫计委科研基金资助项目(编号:WX13C15)
关键词 胃肿瘤 MIR-199A-3P MAP3K4 Stomach neoplosms miR-199a-3p MAP3K4
  • 相关文献

参考文献4

二级参考文献48

  • 1宋长山,杨光,谭家驹.DNA甲基化与食管癌的关系[J].中华肿瘤防治杂志,2007,14(1):71-74. 被引量:12
  • 2Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer 1998; 1:125-133.
  • 3Kunisaki C, Shimada H, Takahashi M, Ookubo K, Moriwaki Y, Akiyama H, Nomura M. Prognostic factors in early gastric cancer. Hepatogastroenterology 2001; 48:294-298.
  • 4Bando E, Kojima N, Kawamura T, Takahashi S, Fukushima N, Yonemura Y. Prognostic value of age and sex in early gastric cancer. Br J Surg 2004; 91:1197-1201.
  • 5Peeters KC, Kattan MW, Hartgrink HH, Kranenbarg EK, Karpeh MS, Brennan MF, van de Velde CJ. Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. Cancer 2005; 103:702-707.
  • 6Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z. Identification of hundreds of conserved and non- conserved human microRNAs. Nat Genet 2005; 37:766-770.
  • 7Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB, Bartel DP. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 2005; 310:1817-1821.
  • 8Negrini M, Ferracin M, Sabbioni S, Croce CM. MicroRNAs in human cancer: from research to therapy. J Cell Sci 2007; 120: 1833-1840.
  • 9Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 10Ahmed FE. Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn 2007; 7: 569-603 [PMID: 17892365 DOE 10.1586/14737159.7.5.569].

共引文献50

同被引文献52

引证文献8

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部